These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 12816906)
41. Impact of antibody specificity and calibration material on the measure of agreement between methods for cardiac troponin I. Newman DJ; Olabiran Y; Bedzyk WD; Chance S; Gorman EG; Price CP Clin Chem; 1999 Jun; 45(6 Pt 1):822-8. PubMed ID: 10351991 [TBL] [Abstract][Full Text] [Related]
42. Association of platelet-monocyte aggregates with platelet activation, systemic inflammation, and myocardial injury in patients with non-st elevation acute coronary syndromes. Zhang SZ; Jin YP; Qin GM; Wang JH Clin Cardiol; 2007 Jan; 30(1):26-31. PubMed ID: 17262778 [TBL] [Abstract][Full Text] [Related]
43. Clinical and analytical performance of the liaison cardiac troponin I assay in unstable coronary artery disease, and the impact of age on the definition of reference limits. A FRISC-II substudy. Venge P; Johnston N; Lagerqvist B; Wallentin L; Lindahl B; Clin Chem; 2003 Jun; 49(6 Pt 1):880-6. PubMed ID: 12765983 [TBL] [Abstract][Full Text] [Related]
44. Earlier detection of myocardial infarction by an improved cardiac TnI assay. Le Moal E; Giuliani I; Bertinchant JP; Polge A; Larue C; Villard-Saussine S Clin Biochem; 2007 Sep; 40(13-14):1065-73. PubMed ID: 17573063 [TBL] [Abstract][Full Text] [Related]
45. Prognostic performance of a high-sensitivity cardiac troponin I assay in patients with non-ST-elevation acute coronary syndrome. Bohula May EA; Bonaca MP; Jarolim P; Antman EM; Braunwald E; Giugliano RP; Newby LK; Sabatine MS; Morrow DA Clin Chem; 2014 Jan; 60(1):158-64. PubMed ID: 24052087 [TBL] [Abstract][Full Text] [Related]
46. Standardization of troponin I measurements: an update. Panteghini M; Bunk DM; Christenson RH; Katrukha A; Porter RA; Schimmel H; Wang L; Tate JR; Clin Chem Lab Med; 2008; 46(11):1501-6. PubMed ID: 18778218 [TBL] [Abstract][Full Text] [Related]
47. Assessing matrix, interferences and comparability between the Abbott Diagnostics and the Beckman Coulter high-sensitivity cardiac troponin I assays. Kavsak PA; Malinowski P; Roy C; Clark L; Lamers S Clin Chem Lab Med; 2018 Jun; 56(7):1176-1181. PubMed ID: 29533903 [TBL] [Abstract][Full Text] [Related]
48. Determination of cardiac troponin I forms in the blood of patients with acute myocardial infarction and patients receiving crystalloid or cold blood cardioplegia. Giuliani I; Bertinchant JP; Granier C; Laprade M; Chocron S; Toubin G; Etievent JP; Larue C; Trinquier S Clin Chem; 1999 Feb; 45(2):213-22. PubMed ID: 9931043 [TBL] [Abstract][Full Text] [Related]
49. Rates of positive cardiac troponin I and creatine kinase MB mass among patients hospitalized for suspected acute coronary syndromes. Lin JC; Apple FS; Murakami MM; Luepker RV Clin Chem; 2004 Feb; 50(2):333-8. PubMed ID: 14670826 [TBL] [Abstract][Full Text] [Related]
50. The lack of standardization of cardiac troponin I assay systems. Tate JR; Heathcote D; Rayfield J; Hickman PE Clin Chim Acta; 1999 Jun; 284(2):141-9. PubMed ID: 10451241 [TBL] [Abstract][Full Text] [Related]
51. Clinical efficacy of three assays for cardiac troponin I for risk stratification in acute coronary syndromes: a Thrombolysis In Myocardial Infarction (TIMI) 11B Substudy. Morrow DA; Rifai N; Tanasijevic MJ; Wybenga DR; de Lemos JA; Antman EM Clin Chem; 2000 Apr; 46(4):453-60. PubMed ID: 10759468 [TBL] [Abstract][Full Text] [Related]
52. Evaluation of standardization capability of current cardiac troponin I assays by a correlation study: results of an IFCC pilot project. Tate JR; Bunk DM; Christenson RH; Barth JH; Katrukha A; Noble JE; Schimmel H; Wang L; Panteghini M; Clin Chem Lab Med; 2015 Apr; 53(5):677-90. PubMed ID: 25999287 [TBL] [Abstract][Full Text] [Related]
53. Comparison of myocardial perfusion imaging and cardiac troponin I in patients admitted to the emergency department with chest pain. Kontos MC; Jesse RL; Anderson FP; Schmidt KL; Ornato JP; Tatum JL Circulation; 1999 Apr; 99(16):2073-8. PubMed ID: 10217644 [TBL] [Abstract][Full Text] [Related]
54. Decreased patient charges following implementation of point-of-care cardiac troponin monitoring in acute coronary syndrome patients in a community hospital cardiology unit. Apple FS; Chung AY; Kogut ME; Bubany S; Murakami MM Clin Chim Acta; 2006 Aug; 370(1-2):191-5. PubMed ID: 16545790 [TBL] [Abstract][Full Text] [Related]
55. Role of monitoring changes in sensitive cardiac troponin I assay results for early diagnosis of myocardial infarction and prediction of risk of adverse events. Apple FS; Pearce LA; Smith SW; Kaczmarek JM; Murakami MM Clin Chem; 2009 May; 55(5):930-7. PubMed ID: 19299542 [TBL] [Abstract][Full Text] [Related]
56. A fluoro-microbead guiding chip for simple and quantifiable immunoassay of cardiac troponin I (cTnI). Song SY; Han YD; Kim K; Yang SS; Yoon HC Biosens Bioelectron; 2011 May; 26(9):3818-24. PubMed ID: 21439810 [TBL] [Abstract][Full Text] [Related]
60. Detection of myocardial injury in patients with unstable angina using a novel nanoparticle cardiac troponin I assay: observations from the PROTECT-TIMI 30 Trial. Wilson SR; Sabatine MS; Braunwald E; Sloan S; Murphy SA; Morrow DA Am Heart J; 2009 Sep; 158(3):386-91. PubMed ID: 19699861 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]